BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
2.260
+0.125 (5.85%)
At close: Nov 22, 2024, 4:00 PM
2.300
+0.040 (1.77%)
After-hours: Nov 22, 2024, 5:26 PM EST

BioCardia Revenue

BioCardia had revenue of $71.00K in the twelve months ending September 30, 2024, down -87.54% year-over-year. In the year 2023, BioCardia had annual revenue of $477.00K, down -64.72%.

Revenue (ttm)
$71.00K
Revenue Growth
-87.54%
P/S Ratio
62.78
Revenue / Employee
$3,550
Employees
20
Market Cap
7.91M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023477.00K-875.00K-64.72%
Dec 31, 20221.35M337.00K33.20%
Dec 31, 20211.02M870.00K600.00%
Dec 31, 2020145.00K-565.00K-79.58%
Dec 31, 2019710.00K85.00K13.60%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ATI Physical Therapy 728.11M
IM Cannabis 38.04M
XWELL 33.83M
Ontrak 11.24M
Applied DNA Sciences 3.40M
Syros Pharmaceuticals 386.00K
Soligenix 364.18K
Cardio Diagnostics Holdings 35.69K
Revenue Rankings